Growing number of biologic therapies offers future opportunities for biosimilar development

Biosimilar medicines critical for future medicines access… 13 December 2023 By 2032, the biosimilar medicines contribution to health systems access…
IQVIA - Assessing the Biosimilar Void 30 October 2023 While biosimilar competition in Europe has played a vital role…
New IQVIA report points to window of opportunity for the EU… 26 October 2023 The EU is currently reviewing its Pharmaceutical Legislation, and the…
EU pharmaceutical legislation reform critical to sustain… 6 October 2022 The EU plans to update its 20-year-old pharmaceutical legislation early…